查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1424386

全球掌腱膜攣縮症市場：依疾病類型、類型、最終用戶、地區

Global Dupuytren's Disease Market, By Disease Type, By Type (Diagnosis and Treatment), By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，全球掌腱膜攣縮症市場規模為43億美元，預估2023年至2030年複合年成長率為4.6%，2030年達59億美元。

掌腱膜攣縮症是一種影響掌筋膜的疾病，掌筋膜是位於皮膚下方並覆蓋手掌和手掌的肌腱、神經、血管和骨骼的一層纖維組織。掌腱膜攣縮症患者的筋膜會隨著時間的推移而增厚和收縮（縮短）。在此過程中，筋膜可能會拉動手指，迫使它們進入手掌內部。結果，伸直手指可能會變得困難或不可能，稱為掌腱膜攣縮。隨著掌腱膜攣縮的惡化，它會影響手部功能並使某些人的日常生活變得困難。在這種情況下，可以採用非手術和手術治療方法來減緩疾病的進展（惡化）並改善受影響手指的活動。掌腱膜攣縮的原因尚不清楚。這種疾病往往有家族遺傳傾向。男性比女性更常見。掌腱膜攣縮症的攣縮多年來緩慢惡化。這種情況始於手掌上出現硬塊。該腫塊可能會或可能不會疼痛。隨著時間的推移，腫塊在皮膚下變成一條硬繩，延伸到手指。這根繩子拉緊手指並將它們拉向手掌，有時甚至很嚴重。

市場動態：

掌腱膜攣縮症盛行率的增加預計將在預測期內推動全球掌腱膜攣縮症市場的成長。例如，根據公共關係和免費媒體軟體公司及服務供應商Cision US Inc. 2022 年 10 月發布的資料，估計北美每年有 1,400 萬人受到掌腱膜攣縮症的影響。

本研究的主要特點

  • 本報告對全球掌腱膜攣縮症市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和複合年成長率。
  • 它還強調了各個細分市場的潛在收益成長機會，並為該市場說明了一系列有吸引力的投資提案。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球掌腱膜攣縮症市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球掌腱膜攣縮症市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球掌腱膜攣縮症市場的各種策略矩陣來促進決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
  • 市場定義和範圍
  • 執行摘要
  • 掌腱膜攣縮症市場，依疾病類型
  • 按類型分類的掌腱膜攣縮症市場
  • 掌腱膜攣縮症市場，依最終用戶分類
  • 掌腱膜攣縮症市場（按地區）
  • Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

  • 市場動態
  • 促進因素
  • 掌腱膜攣縮症盛行率增加
  • 抑制因素
  • 昂貴的治療費用
  • 機會
  • 新興國家
  • 影響分析
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章全球掌腱膜攣縮症市場－冠狀病毒（COVID-19）大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章全球掌腱膜攣縮症市場，依疾病類型，2018-2030

  • 介紹
  • 2023年及2030年市場佔有率分析（%）
  • 與前一年同期比較成長分析，2019-2030
  • 細分市場趨勢
  • Ⅰ型
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率
  • II型
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率
  • Ⅲ型
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率

第6章 全球掌腱膜攣縮症市場，依類型，2018-2030

  • 介紹
  • 2023年及2030年市場佔有率分析（%）
  • 與前一年同期比較成長分析，2019-2030
  • 細分市場趨勢
  • 診斷
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率
  • 體檢
  • X光
  • 流程
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率
  • 外科手術
  • 放射治療
  • 針腱膜切開術
  • 類固醇注射
  • 酵素注射液
  • 職能治療
  • 其他

第 7 章 全球掌腱膜攣縮症市場，依最終使用者分類，2018-2030 年

  • 介紹
  • 2023年及2030年市場佔有率分析（%）
  • 與前一年同期比較成長分析，2019-2030
  • 細分市場趨勢
  • 醫院
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率
  • 診所
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率
  • 學術/研究機構
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率
  • 其他
  • 介紹
  • 2018-2030年市場規模及預測、與前一年同期比較成長率

第8章全球掌腱膜攣縮症市場，按地區，2018-2030

  • 介紹
  • 2023 年和 2030 年按國家/地區分類的市場佔有率分析 (%)
  • 2019-2030與前一年同期比較成長分析（按國家）
  • 各國的趨勢
  • 北美洲
  • 介紹
  • 2018-2030年市場規模及依疾病類型預測、與前一年同期比較成長率
  • 2018-2030年市場規模及按類型預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與預測（按國家）、與前一年同期比較成長率（按國家）
  • 美國
  • 加拿大
  • 歐洲
  • 介紹
  • 2018-2030年市場規模及依疾病類型預測、與前一年同期比較成長率
  • 2018-2030年市場規模及按類型預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與預測（按國家）、與前一年同期比較成長率（按國家）
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 介紹
  • 2018-2030年市場規模及依疾病類型預測、與前一年同期比較成長率
  • 2018-2030年市場規模及按類型預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與預測（按國家）、與前一年同期比較成長率（按國家）
  • 中國
  • 印度
  • 日本
  • 東南亞國協
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 介紹
  • 2018-2030年市場規模及依疾病類型預測、與前一年同期比較成長率
  • 2018-2030年市場規模及按類型預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與預測（按國家）、與前一年同期比較成長率（按國家）
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • 介紹
  • 2018-2030年市場規模及依疾病類型預測、與前一年同期比較成長率
  • 2018-2030年市場規模及按類型預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
  • 2018-2030 年按國家/與前一年同期比較的市場規模和預測、按國家/地區分類的同比成長率
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 介紹
  • 2018-2030年市場規模及依疾病類型預測、與前一年同期比較成長率
  • 2018-2030年市場規模及按類型預測、與前一年同期比較成長率
  • 2018-2030 年市場規模與最終用戶預測、與前一年同期比較成長率
  • 2018-2030年按國家/地區、與前一年同期比較成長率和國家分類的市場規模和預測
  • 北非
  • 中部非洲
  • 南非

第9章 競爭形勢

  • Endo International Plc
  • Bristol-Meyers Squibb Company
  • Spear Pharmaceuticals
  • GSK Plc.
  • AstraZeneca
  • Hikma Pharmaceuticals Plc
  • LEO Pharma A/S
  • Fresenius Kabi AG
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.
  • Nantong Jinghua Pharmaceutical Co., Ltd.
  • Actiza Pharmaceutical Pvt. Ltd.

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6530

The global Dupuytren's disease market size is valued at US$ 4.3 Bn in 2023 and is expected to reach US$ 5.9 Bn by 2030, growing at a compound annual growth rate (CAGR) of 4.6% from 2023 to 2030.

Dupuytren's disease is a condition that affects the palmar fascia - the fibrous layer of tissue that lies underneath the skin and above the tendons, nerves, blood vessels, and bones in the palm and fingers. In patients with Dupuytren's disease, the fascia thickens and contracts (shortens) over time. The fascia may pull on the fingers during this process, causing them to be forced inward, toward the palm. This may make it difficult or impossible to fully straighten the fingers, resulting in what is known as a "Dupuytren's contracture." In some people, a worsening Dupuytren's contracture can interfere with hand function, making it difficult to perform daily activities. When this occurs, there are non-surgical and surgical treatment options available to help slow the progression (worsening) of the disease and improve motion in the affected fingers. The cause of Dupuytren contracture is unknown. The condition tends to run in families. It is more common in men than in women. Dupuytren contracture gets worse slowly, over years. The condition begins with a firm lump in the palm of the hand. This lump can be painful or painless. Over time, the lump can extend into a hard cord under the skin and up into the finger. This cord tightens and pulls the finger toward the palm, sometimes severely.

Market Dynamics:

The increasing prevalence of Dupuytren's disease is expected to drive the growth of the global Dupuytren's disease market over the forecast period. For instance, according to data published in October 2022 by Cision US Inc., a public relations and earned media software company and services provider, an estimated 14 million people are affected by Dupuytren's disease every year in North America.

Key features of the study:

    • This report provides an in-depth analysis of the global Dupuytren's disease market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
    • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
    • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
    • It profiles key players in the global Dupuytren's disease market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
    • Key companies covered as a part of this study include Endo International Plc, Bristol-Meyers Squibb Company, Spear Pharmaceuticals, GSK Plc., AstraZeneca, Hikma Pharmaceuticals Plc, LEO Pharma A/S, Fresenius Kabi AG, Bayer AG, Novartis AG, Pfizer Inc., Nantong Jinghua Pharmaceutical Co., Ltd., and Actiza Pharmaceutical Pvt. Ltd.
    • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
    • The global Dupuytren's disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
    • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Dupuytren's disease market

Detailed Segmentation:

    • Global Dupuytren's Disease Market Segmentation, By Disease Type:
    • Type I
    • Type II
    • Type III
    • Global Dupuytren's Disease Market Segmentation, By Type:
    • Diagnosis
    • Physical Examination
    • X-ray
    • Treatment
    • Surgery
    • Radiation Therapy
    • Needle Aponeurotomy
    • Steroid Shot
    • Enzyme Injection
    • Occupational Therapy
    • Others
    • Global Dupuytren's Disease Market Segmentation, By End User:
    • Hospitals
    • Clinics
    • Academic & Research Institute
    • Others
    • Global Dupuytren's Disease Market Segmentation, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
    • Company Profile:
    • Endo International Plc
    • Bristol-Meyers Squibb Company
    • Spear Pharmaceuticals
    • GSK Plc.
    • AstraZeneca
    • Hikma Pharmaceuticals Plc
    • LEO Pharma A/S
    • Fresenius Kabi AG
    • Bayer AG
    • Novartis AG
    • Pfizer Inc.
    • Nantong Jinghua Pharmaceutical Co., Ltd.
    • Actiza Pharmaceutical Pvt. Ltd.

Table of Contents

1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Dupuytren's Disease , By Disease Type
    • Market Dupuytren's Disease , By Type
    • Market Dupuytren's Disease , By End User
    • Market Dupuytren's Disease , By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Increasing prevalence of Dupuytren's disease
    • Restraints
    • High cost of treatment
    • Opportunities
    • Emerging economies
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER's Analysis
    • Merger and Acquisition Scenario

4. Global Dupuytren's Disease Market - Impact of Coronavirus (COVID-19) Pandemic

    • COVID-19 Epidemiology
    • Supply Side and Demand Side Analysis
    • Economic Impact

5. Global Dupuytren's Disease Market, By Disease Type, 2018-2030, (US$ Bn)

    • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
    • Type I
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Type II
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Type III
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Dupuytren's Disease Market, By Type, 2018-2030, (US$ Bn)

    • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
    • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Physical Examination
    • X-ray
    • Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Surgery
    • Radiation Therapy
    • Needle Aponeurotomy
    • Steroid Shot
    • Enzyme Injection
    • Occupational Therapy
    • Others

7. Global Dupuytren's Disease Market, By End User, 2018-2030, (US$ Bn)

    • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
    • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Academic & Research Institute
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Dupuytren's Disease Market, By Region, 2018-2030, (US$ Bn)

    • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country, 2019 - 2030
    • Country Trends
    • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    • U.S.
    • Canada
    • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 - 2030, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, By Country/Region, Y-o-Y Growth and By Country/Region, 2018 - 2030, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

    • Endo International Plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Bristol-Meyers Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Spear Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • GSK Plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Hikma Pharmaceuticals Plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • LEO Pharma A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Fresenius Kabi AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Nantong Jinghua Pharmaceutical Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Actiza Pharmaceutical Pvt. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
    • Analyst Views

10. Section

    • Research Methodology
    • About us